Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Prins, Martin H; Lensing, Anthonie Wa; Bauersachs, Rupert; van Bellen, Bonno; Bounameaux, Henri; Brighton, Timothy A; Cohen, Alexander T; Davidson, Bruce L; Decousus, Hervé; Raskob, Gary E; Berkowitz, Scott D; Wells, Philip S

doi:10.1186/1477-9560-11-21

Scientific article

English

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

ContributorsPrins, Martin H; Lensing, Anthonie Wa; Bauersachs, Rupert; van Bellen, Bonno; Bounameaux, Henri; Brighton, Timothy A; Cohen, Alexander T; Davidson, Bruce L; Decousus, Hervé; Raskob, Gary E; Berkowitz, Scott D; Wells, Philip S

Published inThrombosis journal, vol. 11, no. 1, 21

Publication date2013

Abstract

Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of anticoagulant effects.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Maladie thromboembolique veineuse (808)

Citation (ISO format)

PRINS, Martin H et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. In: Thrombosis journal, 2013, vol. 11, n° 1, p. 21. doi: 10.1186/1477-9560-11-21

Article (Published version)

Identifiers

PID : unige:29957
DOI : 10.1186/1477-9560-11-21
PMID : 24053656

Additional URL for this publicationhttp://www.thrombosisjournal.com/content/11/1/21

Journal ISSN1477-9560

615views

917downloads

Creation27/09/2013 07:51:00

First validation27/09/2013 07:51:00

Update time09/02/2026 14:32:44

Status update09/02/2026 14:32:44

Last indexation20/04/2026 15:27:27

Archive ouverte UNIGE

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Technical informations